ÌÇÐÄvlog

This Viewpoint discusses the the role of the DNA damage response pathway in disease syndromes and its importance to human health.

In this Viewpoint, Allison discusses discoveries involving regulation of the T-cell response, development of immune checkpoint blockade in cancer therapy, and implications of engaging the immune response as a new modality for cancer treatment.

This Viewpoint discusses the global response to Ebola and the contributions of Médecins Sans Frontières/Doctors Without Borders to this response.

In this Viewpoint, Pomeroy discusses the history of the Lasker Awards and their importance in highlighting the contributions of hundreds of scientists involved in research and public service.

Dr Fauci and coauthors discuss the Lasker Awards that have been granted to scientists for discoveries underlying vaccine development.

This Viewpoint discusses the history of the Lasker Awards.

This commentary by JAMA Oncology Editor Mary L. Disis, MD, outlines advances in oncology through the laboratory discoveries and clinical research by Lasker Award recipients over the last 65 years.

This commentary outlines the history and context of global prizes for health research in the years since the Albert and Mary Lasker Foundation began recognizing biomedical science and clinical research.

This Viewpoint describes early observations about the human microbiota and what research might tell us about the benefits and vulnerabilities of an individual’s microbial ecosystem.

This Viewpoint summarizes new trends in the field of epigenetics and epigenetic epidemiology.